Interview with author Mark Miller .Three Bills Gain Cosponsors .The pharmaceutical industry warns the move could damage its profits and take away incentives to invent new treatments. .TSCL is gearing up to fight legislation that would cut the current rate of COLA growth. "People who depend on Social Security need a COLA that more adequately protects the buying power of their benefits," says Hyland. TSCL believes seniors would receive higher and more adequate benefits by using an index that more closely tracks senior spending, like the Consumer Price Index for the Elderly (CPI-E). TSCL supports The Consumer Price Index for Elderly Consumers (CPI-E) Act, H.R. 798 introduced by Rep. Peter DeFazio (OR-4), and H.R.456 introduced by Charles Gonzalez (TX-20). Learn more by visiting TSCL on the web at . .TSCL encourages its members and supporters to attend these events and to ask questions of their elected officials about important Social Security and Medicare issues, like the following four… .That leaves Grassley with a ticking clock to build enough support for his proposal to get it through the Senate and to convince House leaders to take it up as well. House leadership has its own signature drug pricing measure that is closer to Trump's own order than Grassley's bill. .TSCL believes the regulations could be costly to seniors and to Medicare. Alternative therapy and medical approaches are used by millions of Americans. The Centers for Disease Control and Prevention estimated, that the U.S. public spent between billion to billion on CAM therapies in 1997, an amount that was more than the U.S. public paid out-of-pocket for all hospitalizations in that year, and an amount that was approximately one-half of that paid by the U.S. public for all out-of-pocket physicians' services. ."We believe this unannounced policy of increased enforcement is irresponsible," said Representative Gil Gutknecht (MN) in a letter to the FDA and Customs. Gutknecht also said that the seizures violate the will of Congress, which has for three years denied FDA funding for the purpose of preventing reimportation of prescription drugs for personal use. .As we've found out in our meetings with Congressional staff members, Congress is hearing thousands of complaints from voters who want surprise billing stopped. But, they are also hearing from the health care providers who are making a lot of money from surprise billings and they are fighting back to try and stop or modify legislation. Because of the pressure Congress is receiving from opposing sides, getting legislation to fix the problem is more complicated than you might expect. There are four bills in the Senate to deal with the issue and five in the House.